Cytotoxicity and apoptogenic properties of the standardized extract of Portulaca oleracea on glioblastoma multiforme cancer cell line (U-87): a mechanistic study

Authors

  • Vafa Baradaran Rahimi Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Seyed Hadi Mousavi Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Soroush Haghighi Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran
  • Sina Soheili-Far Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  • Vahid Reza Askari Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran, Tel./Fax: +98-513-800-2262; E-mail: askariv941@mums.ac.ir, vahidrezaaskary@yahoo.com; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

DOI:

https://doi.org/10.17179/excli2019-1063

Keywords:

Glioblastoma multiforme (GBM), ROS, NF-kB, U-87 cell, Portulaca oleracea, nitric oxide

Abstract

The traditional uses of Portulaca oleracea L. (PO) with anti-inflammatory and anti-cancer activity as well as antioxidants properties were expressed previously. Glioma is considered the most common primary brain tumor and its malignant form is the most lethal adult brain tumor, that glioblastoma covers about 50 % of glioma tumors. The present study was aimed to evaluate the cytotoxicity and apoptogenic effects of the hydro-ethanolic extract of PO on human glioblastoma cancer cell line (U-87) and the role of NF‑kB. Cytotoxicity of the extract in the presence or absence of Vitamin C was evaluated using MTT assay, and the following hypotonic PI and SubG1 peak were performed. Moreover, the reactive oxygen species (ROS), the level of NF‑kB protein and nitric oxide (NO) production were investigated. The extract had cytotoxicity and apoptogenic effects on U-87 cells in both the concentration and time-dependent manners. The mechanism of cytotoxicity and apoptosis induction of the extract at the first hours of incubation and low concentrations were dependent on ROS. However, the toxicity was replaced with NO pathway with time-lapse and higher concentrations. Results also indicated that the extract acts as an NF‑kB inhibitor with concentration and time-dependent manners. The present study may suggest the anti-NF‑kB activity of PO along with two upstream ROS and NO mechanisms. Furthermore, the extract as ethnobotanical may be used as adjunctive anti-cancer therapy against glioblastoma multiforme.

Downloads

Published

2019-03-20

How to Cite

Baradaran Rahimi, V., Mousavi, S. H., Haghighi, S., Soheili-Far, S., & Askari, V. R. (2019). Cytotoxicity and apoptogenic properties of the standardized extract of Portulaca oleracea on glioblastoma multiforme cancer cell line (U-87): a mechanistic study. EXCLI Journal, 18, 165–186. https://doi.org/10.17179/excli2019-1063

Issue

Vol. 18 (2019)

Section

Original articles

License

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).

Most read articles by the same author(s)